About MedWaves
MedWaves is a company based in San Diego (United States) founded in 1998. MedWaves has raised $3 million across 1 funding round. MedWaves offers products and services including AveCure Intelligent Therapeutic System, AveCure Intelligent Controller, AveCure Smart Probe, and AveCure Super-Flex Smart Catheter. MedWaves operates in a competitive market with competitors including NxThera, Francis Medical, Combat Medical, Kaio Therapy and Vither Hyperthermia, among others.
- Headquarter San Diego, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Medwaves, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3 M (USD)
in 1 rounds
-
Latest Funding Round
$3 M (USD), Series A
Feb 01, 2008
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of MedWaves
MedWaves offers a comprehensive portfolio of products and services, including AveCure Intelligent Therapeutic System, AveCure Intelligent Controller, AveCure Smart Probe, and AveCure Super-Flex Smart Catheter.
Controls microwave energy for safe soft-tissue disease treatment.
Manages therapeutic procedures with precision and feedback mechanisms.
Delivers targeted energy for biomedical applications.
Enables flexible, minimally invasive treatment options.
Funding Insights of MedWaves
MedWaves has successfully raised a total of $3M through 1 strategic funding round. The most recent funding activity was a Series A round of $3 million completed in February 2008. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by MedWaves
Investment portfolio details for MedWaves
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - MedWaves
Detailed financials for MedWaves
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Medwaves Comparisons
Peer comparison for MedWaves
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of MedWaves
MedWaves operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NxThera, Francis Medical, Combat Medical, Kaio Therapy and Vither Hyperthermia, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Thermal therapy for benign prostatic hyperplasia (BPH) is developed.
|
|
| Locked | Locked | Locked |
Developer of a therapeutic solution to treat prostate, kidney, and bladder cancer
|
|
| Locked | Locked | Locked |
Thermotherapy devices for bladder cancer treatment are manufactured.
|
|
| Locked | Locked | Locked |
Hyperthermia-based cancer therapeutic platform is developed using nanoparticles.
|
|
| Locked | Locked | Locked |
A cancer therapy in which the body is heated to 42°C for 2 hours
|
Detailed competitors of MedWaves
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Medwaves
Complete news archive for MedWaves
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MedWaves
MedWaves was founded in 1998 and raised its 1st funding round 10 years after it was founded.
MedWaves is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
MedWaves is a funded company, having raised a total of $3M across 1 funding round to date.
MedWaves is developing AveCure, a system for the treatment of soft tissue problems using thermal coagulation-ablation. It includes a microwave generator and sterile single-patient-use probes. It uses temperature and power feedback from the antenna and nearby tissue to control microwave power to the ablation zone. The company has received FDA Clearance and CE Mark approval for soft-tissue coagulationablation.
MedWaves's top competitors include Francis Medical, NxThera and Combat Medical.
MedWaves offers AveCure Intelligent Therapeutic System, AveCure Intelligent Controller, AveCure Smart Probe, and AveCure Super-Flex Smart Catheter.